FD
$14.97
+0.27
(+1.84%)
As of Sep 5, 2026, 4:36 PM EDT
Price history
4d Molecular Therapeutics Inc (FDMT) is trading up at $14.97 (+1.84%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
IPO: December 11, 2020 · $23.00 offering · NASDAQ · View IPO details →
Recent News (3)
-
4DMT to Participate in Upcoming Investor Conferences EMERYVILLE, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted…
-
4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population EMERYVILLE, Calif., July 18, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted…
-
4DMT Announces New Employment Inducement Grants EMERYVILLE, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted…
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International